Form 4 holding
Other*, 10%+ Owner
Adagio Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 11,241,580
- Estimated value
- $44,404,241
- Report date
- 28 Mar 2022
- Price
- $3.95
- Ownership
- Direct
MITHRIL II LP
Insider Reports History
- Reporting-owner location
- San Francisco, CA
- Latest reporting-owner signature
- /s/ Ajay Royan, Managing Member, Mithril II UGP LLC, General Partner of Mithril II GP LP, the General Partner of Mithril II LP
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for MITHRIL II LP
Insider Reports Filed by MITHRIL II LP
4
IVVD
Adagio Therapeutics, Inc.
- Report period
- 28 Mar 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 30 Mar 2022, 21:02
- Role
- Other*, 10%+ Owner
- Next action
- Open filing details
4
IVVD
Adagio Therapeutics, Inc.
- Report period
- 10 Aug 2021
- Transactions
- 5
- Transaction value
- +$33,949,000
- Accepted by SEC
- 12 Aug 2021, 21:25
- Role
- 10%+ Owner
- Next action
- Open filing details
3/A
IVVD
Adagio Therapeutics, Inc.
- Report period
- 05 Aug 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 12 Aug 2021, 21:21
- Role
- 10%+ Owner
- Next action
- Open filing details